Refine by
Autoimmune Disease Articles & Analysis: This-Week
1 articles found
Blocking CCR1 can blunt harmful inflammation but risks impairing protective immunity. Clinical Relevance: From Autoimmunity to Oncology In autoimmune diseases such as multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease, CCR1 signaling sustains leukocyte infiltration into tissues. Elevated CCR1 expression ...